Melody Chang, RPh, MBA, BCOP, director of pharmacy operations for Florida Cancer Specialists & Research Institute (FCS), has published an article concerning the ongoing controversy surrounding the treatment of cancer patients with medical marijuana or other cannabinoid-derived products.
Florida Cancer Specialists & Research Institute (FCS) physicians are the co-authors of 20 research studies that will be presented at the American Society of Clinical Oncology (ASCO®) ASCO20 Virtual Scientific Program being held May 29 – 31, 2020.
Despite the many challenges of the current health care crisis, patients of Florida Cancer Specialists & Research Institute (FCS) report high satisfaction with the oncology provider’s response and efforts to provide care safely, and with little or no disruption.
Florida Cancer Specialists & Research Institute (FCS) recently launched telehealth services across all FCS sites statewide, allowing patients continued and convenient access to care, while mitigating the impact and spread of COVID-19. This virtual care solution plays a vital role in response to the pandemic crisis, maintaining patient access to care directly from home. FCS was among the first cancer care groups in Florida to launch telehealth resources to cancer patients during the pandemic.
Florida Cancer Specialists & Research Institute (FCS) will expand access to comprehensive cancer treatment and opportunities for patients to participate in cutting-edge cancer research with the opening of its FCS Cancer Center and Sarah Cannon Research Institute Drug Development Unit in Lake Mary later this month.
Florida Cancer Specialists & Research Institute (FCS) has met the accreditation standards required by the Better Business Bureau for membership and has received the organization’s A+ rating.
FCS Top News Updates
FCS Contributing To Breakthroughs In Treatment of Blood Cancers & Disorders
Melody Chang, RPh, MBA, BCOP, Publishes Comprehensive Article Examining Medical Marijuana for Cancer PatientsMelody Chang, RPh, MBA, BCOP, director of pharmacy operations for Florida Cancer Specialists & Research Institute (FCS), has published an article concerning the ongoing controversy surrounding the treatment of cancer patients with medical marijuana or other cannabinoid-derived products.
Florida Cancer Specialists Participation at ASCO® Demonstrates Progress Made Through Clinical ResearchFlorida Cancer Specialists & Research Institute (FCS) physicians are the co-authors of 20 research studies that will be presented at the American Society of Clinical Oncology (ASCO®) ASCO20 Virtual Scientific Program being held May 29 – 31, 2020.
Cancer Patients Report High Satisfaction with Care During COVID-19 PandemicDespite the many challenges of the current health care crisis, patients of Florida Cancer Specialists & Research Institute (FCS) report high satisfaction with the oncology provider’s response and efforts to provide care safely, and with little or no disruption.
Florida Cancer Specialists & Research Institute Provides Hypofractionation Radiation TherapyAdvanced radiation therapy options lead to faster and shorter rounds of radiation therapy for patients with certain types of cancer.
Florida Cancer Specialists Launches Telehealth Services in Response to Coronavirus (COVID-19)Florida Cancer Specialists & Research Institute (FCS) recently launched telehealth services across all FCS sites statewide, allowing patients continued and convenient access to care, while mitigating the impact and spread of COVID-19. This virtual care solution plays a vital role in response to the pandemic crisis, maintaining patient access to care directly from home. FCS was among the first cancer care groups in Florida to launch telehealth resources to cancer patients during the pandemic.
Ribbon cutting for FCS Lake Mary Cancer Center and Sarah Cannon Drug Development UnitToday we cut the ribbon to celebrate our new FCS Lake Mary Cancer Center and Sarah Cannon Research Institute Drug Development Unit at FCS!
Florida Cancer Specialists Expanding Cancer Care Treatment Services & Opening First of its Kind Drug Development Unit with Sarah Cannon Research Institute in Central FloridaFlorida Cancer Specialists & Research Institute (FCS) will expand access to comprehensive cancer treatment and opportunities for patients to participate in cutting-edge cancer research with the opening of its FCS Cancer Center and Sarah Cannon Research Institute Drug Development Unit in Lake Mary later this month.
Florida Cancer Specialists & Research Institute Receives Accreditation and A+ Rating from Better Business BureauFlorida Cancer Specialists & Research Institute (FCS) has met the accreditation standards required by the Better Business Bureau for membership and has received the organization’s A+ rating.